What Researchers Did
Researchers conducted a systematic review to evaluate the benefits of hyperbaric oxygen therapy in preventing and managing radiation-induced complications in head and neck cancer patients.
What They Found
The review found that hyperbaric oxygen therapy was effective in improving subjective symptoms of xerostomia, swallowing, speech, and overall quality of life in head and neck cancer patients. However, there was no conclusive evidence to demonstrate that HBO improved dental implant survival, prevented osteonecrosis, or enhanced salivary gland function.
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for head and neck cancer might experience improved quality of life, including better speech and swallowing, with hyperbaric oxygen therapy. However, the high costs and limited accessibility of HBO therapy should be carefully considered against its potential benefits for individual patients.
Canadian Relevance
This systematic review did not include any specific Canadian data or studies.
Study Limitations
The review highlighted a lack of conclusive evidence for several potential benefits of hyperbaric oxygen therapy, suggesting gaps in current research.